| 发明名称 |
PHARMACEUTICAL FORMULATION COMPRISING LOSARTAN POTASSIUM AND CHLORTHALIDONE |
| 摘要 |
The invention is a pharmaceutical tablet formulation comprising between about 2.5 mg and 100 mg losartan potassium, between about 6.25 mg and about 50 mg chlorthalidone, and sodium bicarbonate in an amount between about 1.0% and about 10.0% by weight. |
| 申请公布号 |
EP3073995(A1) |
申请公布日期 |
2016.10.05 |
| 申请号 |
EP20140802069 |
申请日期 |
2014.11.24 |
| 申请人 |
MERCK SHARP & DOHME B.V. |
发明人 |
FALIVENE ALDEA, ALBERT;WIJGERGANGS, JAN-PIET;ZWINKELS, JOCOMINUS ANTONIUS MARIA |
| 分类号 |
A61K9/20;A61K9/00;A61K9/46;A61K31/4178 |
主分类号 |
A61K9/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
